Pharmacokinetics of thalidomide in dogs: can feeding affect it? A preliminary study

BACKGROUND: Tumor-associated neoangiogenesis is a crucial target for antitumor therapies. Thalidomide (TAL) is a promising anti-neoangiogenetic drug that has recently been used in the treatment of several malignancies in dogs. OBJECTIVES: The aim of the study was to assess the pharmacokinetics of TA...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierini, Alessio, Sartini, Irene, Giorgi, Mario, Łebkowska-Wieruszewska, Beata, Lisowski, Andrzej, Poapolathep, Amnart, Marchetti, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Veterinary Science 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533387/
https://www.ncbi.nlm.nih.gov/pubmed/33016014
http://dx.doi.org/10.4142/jvs.2020.21.e60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533387/
https://www.ncbi.nlm.nih.gov/pubmed/33016014
http://dx.doi.org/10.4142/jvs.2020.21.e60

Ejemplares similares